Skip to main content
. Author manuscript; available in PMC: 2020 Sep 30.
Published in final edited form as: Vaccine. 2019 Sep 5;37(42):6208–6220. doi: 10.1016/j.vaccine.2019.08.030

Figure 3. Characterization of TLR conjugated HA-NPs.

Figure 3.

(A) Molecular structures of the linker-TLR7/8-agonist complex and linker-TLR9-agonist complex are shown. (B) Electron micrographs of particles before and after conjugation confirm intact nanoparticle formation.